Skip to main content

Month: September 2022

Witness Blanket goes digital to share truths and memories of residential school Survivors

Supported by a $1 million commitment from TELUS in partnership with the Canadian Museum for Human Rights and Indigenous artist Carey Newman, witnessblanket.ca invite users to listen, learn and explore the stories behind the dynamic artworkDigital Witness Blanket Witness Blanket goes digital to share truths and memories of residential school SurvivorsVANCOUVER, XʷMƏΘKʷƏY̓ƏM (Musqueam), SḴWX̱WÚ7MESH (Squamish), and SƏLILWƏTAɬ (Tsleil-Waututh) Territories, Sept. 19, 2022 (GLOBE NEWSWIRE) — Today, the Canadian Museum for Human Rights (CMHR), Indigenous artist Carey Newman (Hayalthkin’geme), and TELUS celebrated the launch of a new online platform which invites all Canadians to bear witness to the experiences of residential school Survivors. Witnessblanket.ca shares stories from the Witness Blanket, a powerful work of art made from...

Continue reading

Global Business Process Outsourcing (BPO) Market to Generate Sales of $492.45 Billion By 2028 | Top 10 Players Generate 60% Market Revenue

Global Business Process Outsourcing (BPO) Market Size was valued at USD 251.1 billion in 2021, and it is expected to reach a value of USD 492.45 billion by 2028, at a CAGR of 10.1% over the forecast period (2022-2028). Westford, USA, Sept. 19, 2022 (GLOBE NEWSWIRE) — As businesses continue to grow, the need for efficient and effective business processes rises. Outsourcing these processes can be a cost-effective way to achieve this goal, as well reasonable to oversee and maintain. This growth in Business Process Outsourcing (BPO) Market has led to the development of a number of different outsourcing options, from manual process outsourcing to enterprise resource planning (ERP) outsourcing. Manual process outsourcing involves contracting outside help to complete certain tasks within a company. This approach can be cost-effective,...

Continue reading

Medical Robots market to Worth 29.30 billion by 2028 | Installation of Surgical Robots to Surpass 2,112 by 2025 – SkyQuest Technology

Global medical robots market was valued at USD 8.40 billion in 2021 and it is expected to reach at USD 29.30 billion by 2028, with CAGR of 22.15% over the forecast period (2022–2028). Westford, USA, Sept. 19, 2022 (GLOBE NEWSWIRE) — As the world undergoes rapid technological advancements, so too does the medical field. Medical robots are specifically designed to assist doctors in performing surgery and other medical procedures more safely and efficiently. Their growing popularity in the global medical robots market is due in part to their reduced risk of human error, as well as the cost-effectiveness of their use. There are a variety of medical robots on the market today, each with its own unique capabilities. Some are designed for basic tasks such as walking or x-ray scanning, while others are specifically designed for more complex...

Continue reading

Veru Announces FDA has Updated the Meeting Date for the Advisory Committee Meeting to Review Emergency Use Authorization for Sabizabulin for Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome

–Advisory Committee Meeting with Same Agenda Has Been Rescheduled to November 09, 2022– MIAMI, Sept. 19, 2022 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases and for the management of breast and prostate cancers, today announced that the U.S. Food and Drug Administration (FDA) has informed the Company of an updated meeting date for the FDA’s Pulmonary-Allergy Drugs Advisory Committee to discuss the Company’s request for Emergency Use Authorization of sabizabulin for hospitalized COVID-19 patients who are at high risk for ARDS. Although the meeting has been rescheduled to November 09, 2022, the agenda has not changed according to the notification published in the Federal Register. About Veru Inc.Veru...

Continue reading

Notification of the appointment of the auditor of Admiral Markets AS for the financial year

Admiral Markets AS (AM AS) announces that the sole shareholder of the company, Admirals Group AS, has appointed the auditing company AS PricewaterhouseCoopers (registry code 10142876) as the company’s auditor for the financial year 2022. The auditor is remunerated in accordance with the contract to be concluded.  Further information:  Kaia Gil Communication Manager of Admiral Markets AS kaia.gil@admiralmarkets.com +372 53 413 764    

Continue reading

Notification of the appointment of the auditor of Admirals Group AS for the financial year

Admirals Group AS announces that it has appointed the auditing company AS PricewaterhouseCoopers (registry code 10142876) as the company’s auditor for the financial year 2022. The auditor is remunerated in accordance with the contract to be concluded.  Further information: Kaia Gil Communication Manager of Admiral Markets AS kaia.gil@admiralmarkets.com +372 53 413 764

Continue reading

Swedbank, together with OP Bank, refinanced a previous loan of Ozo turtas, a company which manages Akropolis Vilnius 

Bank Swedbank, a banking leader in Lithuania, together with Finnish capital bank OP Corporate Bank, gave a syndicated loan of EUR 159.5 million to Ozo turtas that manages the shopping centre Akropolis Vilnius. Swedbank in Lithuania is the arranger and agent of this syndicated loan. “In the second half of this year, the business faces even more challenges than at the beginning of the year – the uncertainty brought by the war in Ukraine and high inflation now go with multiple increase of energy costs, also a significant increase of interest rates. We greatly appreciate the trust in our business demonstrated by Swedbank and OP Bank. Effective management and planning of finances is particularly important for successful business and its stability. We will use most of the new loan to refinance the previous loan, also for strengthening of group’s...

Continue reading

Andrew Peller Limited Announces the Final 2022 Annual Meeting Voting Results

GRIMSBY, Ontario, Sept. 19, 2022 (GLOBE NEWSWIRE) — Andrew Peller Limited ADW.A / ADW.B (“APL” or the “Company”) announced the final voting results from its 2022 annual meeting (the “Meeting”) of shareholders held on September 14, 2022.  The total number of Class B Voting Shares represented by shareholders present in person or by proxy at the Meeting was 20, representing 65.2% of the 8,144,183 voting shares issued and outstanding as of the record date.       1.  Election of Directors – The following six nominees were elected to serve as directors. The nominees and respective term limits were listed in the Company’s management information circular dated July 29, 2022:Nominee # Votes For % Votes For # Votes Against % Votes AgainstShauneen E. Bruder 5,235,463 98.59% 74,806 1.41%Perry J. Miele 5,235,458 98.59% 74,811 1.41%David...

Continue reading

Global Melatonin Market to Reach $3.93 Billion By 2028 | Consumers are looking to Explore in New Products and Services Related to Melatonin

Global melatonin market was valued at US$ 1.51 Billion in 2021, and it is expected to reach a value of US$ 3.93 Billion by 2028, at a CAGR of 14.81% over the forecast period (2022–2028). Westford, USA, Sept. 19, 2022 (GLOBE NEWSWIRE) — Melatonin is a naturally occurring hormone that is produced during sleep and regulates numerous physiological processes in the body. Consequently, demand for this compound has been increasing over the last decade across the global melatonin market. A number of studies have indicated that melatonin can improve sleep quality, reduce inflammation, and protect against neurodegenerative diseases. Consequently, there is growing demand for this compound from consumers and investors alike. The popularity of melatonin market, a hormone that helps to regulate sleep, is on the rise. Manufacturers are developing...

Continue reading

Red White & Bloom Announces Restructuring of Over CDN $110 Million of Debentures and Management Changes

Appointment of Colby De Zen as President and Director of Red White & Bloom Brands Inc. effective immediately; Gabriel Bianchi to Join the Board of Directors upon completion of regulatory requirements; An Aggregate of USD $70 million of current loans amended with maturity now in 2024; CDN $17 million new convertible debenture issued at a conversion price representing a 67% premium to the closing price and maturity in 2024; CDN $2.1 million current loan amended with maturity now in 2024; Over CDN $100 million of current liabilities to be moved to long-term liabilities.TORONTO, Sept. 19, 2022 (GLOBE NEWSWIRE) — Red White & Bloom Brands Inc. (CSE: RWB and OTC: RWBYF) (“RWB” or the “Company”) a multi-state cannabis operator and house of premium brands, is pleased to announce the appointment of Colby...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.